Quantifying Airway Inflammation With Radiologic Tests

Status Completed

Clinical Trial Summary

In this randomized, double-blind, placebo controlled trial we used positron emission tomography to determine if lovastatin or recombinant human activated protein C exhibit anti-inflammatory effects in humans following intrabronchial installation of lipopolysaccharide (LPS or endotoxin).

Clinical Trial Description

Quantitative, noninvasive biomarkers for lung-specific inflammation have yet to be developed but can potentially contribute significantly to the development of therapies to treat lung inflammation. The purpose of this study was to demonstrate that positron emission tomographic (PET) imaging with [18F}fluorodeoxyglucose (FDG-PET) can be used to quantify the change in lung inflammation in healthy volunteers. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00741013
Study type	Interventional
Source	Washington University School of Medicine
Contact
Status	Completed
Phase	Phase 0
Start date	March 2007
Completion date	March 2008

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT03309358` - A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis	Phase 1
Recruiting	`NCT04115514` - Treatment of ARDS With Instilled T3	Phase 2
Completed	`NCT02277002` - Commuter Air Pollution Intervention Study	N/A
Completed	`NCT05260827` - The Effects of Heated Tobacco Products Use on Lung Function and Volatile Organic Compounds in Exhaled Air	N/A
Completed	`NCT04606069` - Treat COVID-19 Patients With Regadenoson	Phase 1/Phase 2
Completed	`NCT02151552` - Assessing NOS Uptake With PET Imaging in Lung Inflammation	Early Phase 1
Recruiting	`NCT05854563` - Cough Capture as a Portal Into the Lung
Active, not recruiting	`NCT05752019` - TAAI Erasmus Research Initiative to Fight CF: Monitoring Inflammation in CF Lung Disease Into a New Era
Completed	`NCT01174056` - Evaluation of Rosiglitazone Anti-inflammatory Effect With FDG-PET Imaging	Phase 0
Completed	`NCT02743468` - Cytochrome P450 Epoxygenase Pathway Regulation of Macrophage Function
Recruiting	`NCT04755478` - LUS to Assess Lung Injury After Lung Lobectomy
Completed	`NCT03905837` - Impact of Lidocaine Administration on Postoperative Complications During Lung Resection Surgery	Phase 4
Recruiting	`NCT03312712` - Validation of the Analysis Methodology Behind the Use of Quantitative 18F-FDG PET/CT to Assess Lung Inflammation
Recruiting	`NCT03492762` - PET Imaging CCR2 in Lung Inflammation	Early Phase 1
Recruiting	`NCT04677309` - LUS to Assess Lung Injury After Lung Resection
Terminated	`NCT02848586` - Effects of E-cigarettes (ECIGs) on Pulmonary Inflammation and Behavior in HIV Infected Smokers	N/A
Enrolling by invitation	`NCT04781153` - Bergen Oral Respiratory Intervention Study	N/A
Withdrawn	`NCT04782700` - P-Co-Li (Pulmonary Covid-19 Study)	N/A